Perez R, Pascual MR, Macias A et al. Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 1984; 4: 189–193. Rios MA, Macias A, Perez R et al. Receptors for epidermal growth factor in human carcinomas and their metastases. Anticancer Res 1988; 8: 173–176. Bartlett JM, Langdon SP, Simpson BJ et al. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer 1996; 73: 301–306. Chow N-H, Liu H-S, Lee EI et al. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res 1997; 17: 1293–1296. Grandis JR, Melhem MF, Gooding WE et al. Levels of TGF-a and EGF-R protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998; 90: 824–832. Volm M, Rittgen W, Drings P. Prognostic value of ERB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinoma. Br J Cancer 1998; 77: 663–669. Maurizi M, Almadori G, Ferrandina G et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996; 74: 1253–1257. 8. Pavelic K, Banjac Z, Pavelic J et al. Evidence for a role of EGF receptor in the progression of human lung carcinoma. Anticancer Res 1993; 13: 1133–1137. Veale D, Kerr N, Gibson GJ et al. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br J Cancer 1993; 68: 162–165. Rusch V, Baselga J, Cordon-Cardo C et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 1993; 53: 2379– 2385. Shin DM, Donato NJ, Perez-Soler R et al. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res 2001; 5: 1204–1207.